Roles of Activated Collagen V Stroma in Translant Rejection and Arteriopathies
活化的 V 型胶原基质在移植排斥和动脉病中的作用
基本信息
- 批准号:7810359
- 负责人:
- 金额:$ 35.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-15 至 2015-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAdherenceAdoptive TransferAdultAffectAffinityAntibodiesApolipoprotein EApoptosisArterial DisorderArterial Fatty StreakAtherosclerosisAutoimmune ProcessAutoimmune ResponsesAutoimmunityBackBehaviorBindingBiological ModelsBronchiolitisCellsCellular ImmunityChoristomaChronicCollagenCollagen ReceptorsCoronary arteryDataDepositionDifferential ThresholdDoxycyclineEpithelial CellsEpitheliumEpitopesExtracellular MatrixFeedbackFibrillar CollagenFractionationGenesGraft RejectionGrowthHeart TransplantationHeart-Lung TransplantationHumanImmuneImmune SeraIn VitroInflammatoryInjuryKnock-in MouseKnock-outKnockout MiceLesionLinkLungMolecularMusMutationNatureOrgan TransplantationPathogenesisPathologic ProcessesPathologyPeptidesProteinsRNARattusRelative (related person)ReportingRodentRoleSeriesSmooth Muscle MyocytesSodium ChlorideStaining methodStainsStructureT-LymphocyteTechnologyTestingTissuesTransgenesTransplantationVascular DiseasesWorkallograft rejectionbasecell typecytokineheart allografthomologous recombinationhuman diseaseimprovedin vivoinsightlung allograftmigrationmouse modelnovelpromoterresearch study
项目摘要
We've reported major roles for autoimmunity to the alpha 1 (V) of collagen V [col(V)] in acute and chronic
lung transplant rejection. Data from these studies led us to hypothesize that abnormal homotrimers of alpha
1(V) chains induce anti-col(V) autoimmunity and organ transplant rejecfion. To test the hypothesis, we
invesfigated whether the autoimmune component of atherosclerosis involves anfi-col(V) autoimmunity,
based solely on the fact that alpha 1 (V) homotrimers are found in human atherosclerotic plaques. Here we
demonstrate that atherosclerosis in humans and rodents is in fact associated with anfi-col(V) autoimmunity,
constituting an important proof-of-concept in support ofthe link between alpha 1(V) homotrimer formafion
and anti-col(V) autoimmunity. We propose studies to demonstrate that aberrent alpha 1(V) homotrimers are
expressed in obliterative bronchiolitis (OB), which underiies chronic lung transplant rejection; and in cardiac
allograft vasculopathy (CAV), an atherosclerosis-like rejection pathology in heart transplants. We will also
use homologous recombinafion to condifionally induce expression of alpha 1(V) homotrimers in vivo in
mouse adult lung epithelium, adult smooth muscle cells, and in ali adult tissues that normally express col(V)
to directly test the roles of this aberrant form of col(V) in OB and CAV, upon lung and heart transplantation,
respectively; and in atherosclerosis, upon crossing of alpha 1 (V) homotrimer-expressing mice with ApoE-null
mice. Various types of immune challenges and adoptive transfers will further test the roles of alpha 1 (V)
homotrimers in initiating anti-col(V) autoimmunity in these novel mouse model systems. We will also employ homologous recombination to generate mice in which alpha 1 (V) epitopes, found by peptide analysis to be the most recognized by anti-col(V) reactive T cells and antibodies, are removed from the alpha 1(V) gene in vivo, to test the true roles of such epitopes in OB, CAV, atherosclerosis and anti-col(V) autoimmunity. Finally, we propose a series of in vitro and in vivo experiments to test the concept of an "activated" alpha 1(V)-
containing stroma that can enhance and perpetuate pathological states, including OB, CAV, atherosclerosis, and perhaps other pathologies as well, and how such a stroma affects cellular behaviors.
我们已经报道了对胶原蛋白α 1 (V) [col(V)]自身免疫在急性和慢性中的主要作用
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DANIEL S GREENSPAN其他文献
DANIEL S GREENSPAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DANIEL S GREENSPAN', 18)}}的其他基金
Defining Key Roles for BMP1-like proteases and ECM in the formation, maintenance, and pathologies of skin and white adipose tissue
定义 BMP1 样蛋白酶和 ECM 在皮肤和白色脂肪组织的形成、维护和病理学中的关键作用
- 批准号:
9893628 - 财政年份:2020
- 资助金额:
$ 35.69万 - 项目类别:
PROCOLLAGEN C-PROTEINASE ENHANCERS: IN VIVO ROLES
原胶原 C-蛋白酶增强剂:体内作用
- 批准号:
7811594 - 财政年份:2009
- 资助金额:
$ 35.69万 - 项目类别:
BMP-1-like protease effects on growth factors & hormones
BMP-1 样蛋白酶对生长因子的影响
- 批准号:
6812089 - 财政年份:2004
- 资助金额:
$ 35.69万 - 项目类别:
BMP-1-like protease effects on growth factors and hormones
BMP-1 样蛋白酶对生长因子和激素的影响
- 批准号:
7279269 - 财政年份:2004
- 资助金额:
$ 35.69万 - 项目类别:
BMP-1-like protease effects on growth factors & hormones
BMP-1 样蛋白酶对生长因子的影响
- 批准号:
6931027 - 财政年份:2004
- 资助金额:
$ 35.69万 - 项目类别:
BMP-1-like protease effects on growth factors & hormones
BMP-1 样蛋白酶对生长因子的影响
- 批准号:
7117259 - 财政年份:2004
- 资助金额:
$ 35.69万 - 项目类别:
BMP-1, MAMMALIAN TOLLOID AND RELATED DEVELOPMENTAL GENES
BMP-1、哺乳动物 Tolloid 和相关发育基因
- 批准号:
2083349 - 财政年份:1996
- 资助金额:
$ 35.69万 - 项目类别:
Procollagen C-Proteinase Enhancers: In vivo Roles
原胶原 C-蛋白酶增强剂:体内作用
- 批准号:
7480346 - 财政年份:1996
- 资助金额:
$ 35.69万 - 项目类别:
Procollagen C-Proteinase Enhancers: In vivo Roles
原胶原 C-蛋白酶增强剂:体内作用
- 批准号:
7201752 - 财政年份:1996
- 资助金额:
$ 35.69万 - 项目类别:
BMP-1, Mammalian Tolloid and Realted Developmental Genes
BMP-1、哺乳动物 Tolloid 和相关发育基因
- 批准号:
6636681 - 财政年份:1996
- 资助金额:
$ 35.69万 - 项目类别:
相似海外基金
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 35.69万 - 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
- 批准号:
10738120 - 财政年份:2023
- 资助金额:
$ 35.69万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10526768 - 财政年份:2022
- 资助金额:
$ 35.69万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10701072 - 财政年份:2022
- 资助金额:
$ 35.69万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10679092 - 财政年份:2021
- 资助金额:
$ 35.69万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10432133 - 财政年份:2021
- 资助金额:
$ 35.69万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10327065 - 财政年份:2021
- 资助金额:
$ 35.69万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10377366 - 财政年份:2019
- 资助金额:
$ 35.69万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10574496 - 财政年份:2019
- 资助金额:
$ 35.69万 - 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
- 批准号:
9403567 - 财政年份:2017
- 资助金额:
$ 35.69万 - 项目类别:














{{item.name}}会员




